Rosacea: Årsaker
Årsaken til rosacea er ukjent, men forskerne tror at sykdommen skyldes en kombinasjon av arvelig disposisjon og miljøfaktorer. En teori er at sykdom i blodårene får blodårene i ansiktet til å hovne opp. En annen teori er at kroppen reagerer og danner antistoffer mot harmløse og normalt forekommende hudbakterier. Mange mennesker med rosacea har solskadet hud, og en antar at dette kan bidra til tilstanden. Men ingen av teoriene er bevist. Alkoholinntak kan forverre plagene hos noen, men alkohol er ikke årsak til sykdommen.
Nordeuropeere med sin lyse hud ser ut til å være mer disponert for rosacea enn folk fra andre områder av kloden.
Selv om den nøyaktige årsaken til rosacea er et mysterium, så finnes det en rekke faktorer som kan utløse tilstanden eller forverre den ved å øke blodstrømmen til hudoverflaten i ansiktet. Noen av disse faktorene er:
- Varm mat eller drikke, eller sterkt krydret mat
- Alkohol
- Ekstreme temperaturer, sollys
- Stress
- Medisiner
Vil du vite mer
Dette dokumentet er basert på det profesjonelle dokumentet Rosacea . Referanselisten for dette dokumentet vises nedenfor
- van Zuuren EJ. Rosacea. N Engl J Med 2017; 377: 1754-64. pmid:29091565 PubMed
- Oge LK, Muncie HL, Phillips-Savoy AR. Rosacea: Diagnosis and treatment. Am Fam Physician. 2015 Aug 1;92(3):187-196.
- Huldt-Nystrøm T, Rørtveit S. Rosacea. Lindbæk M red. Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Oslo: Helsedirektoratet, sist oppdatert 01.12.2016.
- Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the U.K. Br J Dermatol. 2012;167(3):598–605.
- Yang X. Relationship between Helicobacter pylori and Rosacea: review and discussion. BMC Infect Dis. 2018 Jul 11;18(1):318. PMID: 29996790 PubMed
- Gravina AG, Federico A, Ruocco E, et al. Helicobacter pylori infection but not small intestinal overgrowth may play a pathogenetic role in rosacea. United European Gastroenterology Journal 2015; 3: 17-24. doi:10.1177/2050640614559262 DOI
- Yamasaki K, Di Nardo A, Bardan A et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007; 13: 975-81. PubMed
- Whitfeld M, Gunasingam N, Leow JL, et al. Staphylococcus epidermidis: A possible role in the pustules of rosacea. J Am Acad Dermatol 2011; 64(1): 49-52. PMID: 20943287 PubMed
- Aroni K, Tsagroni E, Kavantzas N, et al. Study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Arch Dermatol Res 2008; 300: 125-31. pmid:18071725 PubMed
- Kligman AM. A personal critique on the state of knowledge of rosacea. Dermatology. 2004;208(3):191–197.
- Jarell, AD. Rosacea. BMJ Best Practice. Last reviewed 30 Sep, 2020. bestpractice.bmj.com
- Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69(6 suppl 1):S15–S26.
- Su D, Drummond PD. Blushing propensity and psychological distress in people with rosacea. Clin Psychol Psychother. 2012;19(6):488-95. PMID: 21698719 PubMed
- Goldgar C, Keahey DJ, Houchins J. Treatment options for acne rosacea. Am Fam Physician 2009; 80: 461-8. American Family Physician
- Maier LE. Management of rosacea. UpToDate, last updated Feb 24, 2020. UpToDate
- van Zuuren EJ, Fedorowicz Z, Carter B, et al. Interventions for rosacea. Cochrane Database of Systematic Reviews 2015, Issue 4. Art. No.: CD003262. DOI: 10.1002/14651858.CD003262.pub5. DOI
- Del Rosso JQ, Webster GF, Jackson M, et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol 2007; 56: 791–802. PMID: 17367893 PubMed
- Sanchez J, Somolinos AL, Almodóvar PI, et al. A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea. J Am Acad Dermatol 2005; 53: 791. pmid:16243127 PubMed
- Webster GF. An open-label, community-based, 12-week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads). Cutis 2010; 86: 7. pmid:21229826 PubMed
- Taieb A, Khemis A, Ruzicka T, et al. Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study. Journal of the European Academy of Dermatology and Venereology, 2015. PMID: 26691278 PubMed
- Bernstein EF, Schomacker K, Paranjape A, Jones CJ. Pulsed dye laser treatment of rosacea using a novel 15 mm diameter treatment beam. Lasers Surg Med. 2018 Oct;50(8):808-812. Epub 2018 Apr 10. PMID: 29635699 PubMed
- Tanghetti E, Del Rosso JQ, Thiboutot D, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 4: a status report on physical modalities and devices. Cutis. 2014;93(2):71–76.
- Krausz AE, Goldberg DJ, Ciocon DH, Tinklepaugh AJ. Procedural management of rhinophyma: A comprehensive review. J Cosmet Dermatol 2018; 17: 960-7. pmid:30225926 PubMed
- Cuevas P, Angulo J, Giménez-Gallego G. Long term effectiveness of dobesilate in the treatment of papulopustular rosacea. BMJ Case Reports 2012; : doi:10.1136/bcr.08.2011.4579 . DOI
- Hua TC, Chung PI, Chen YJ, et al. Cardiovascular comorbidities in patients with rosacea: A nationwide case-control study from Taiwan. J Am Acad Dermatol 2015; 73: 249-54. DOI: 10.1016/j.jaad.2015.04.028 DOI